Biolegend, 423112, Zombie Green™ Fixable Viability Kit
500tests
Catalog Number: 423112
Send an RFQ.
Category
Pack Size1 vial
Loading…
| Preparation | Zombie Green™ Fixable Viability Kit is composed of lyophilized Zombie Green™ dye and anhydrous DMSO. For reconstitution, bring the kit to room temperature; add 100 µl of DMSO to one vial of Zombie Green™ dye until fully dissolved. 100 tests = 1 vial of Zombie Green™ + DMSO, 500 tests = 5 vials of Zombie Green™ + DMSO. |
|---|---|
| Storage & Handling | Store kit at -20°C upon receipt. Do not open vials until needed. Once the DMSO is added to the Zombie Green™ dye, use immediately, or store at -20°C in a dry place and protected from light, preferably in a desiccator or in a container with desiccant for no more than one month. |
| Application | FC - Quality tested ICFC, ICC - Verified |
| Recommended Usage | Each lot of this product is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometry, the suggested dilution is 1:100-1:1000 for 1-10 million cells. For immunocytochemistry, the suggested dilution is 1:1000. It is recommended that the reagent be titrated for optimal performance for each application, as optimal dosage varies with cell type. This product is provided under an intellectual property license from Life Technologies Corporation.View full statement regarding label licenses |
| Excitation Laser | Blue Laser (488 nm) |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Application Notes | Zombie Green™ dye is excited by the blue laser (488 nm) and has a fluorescence emission maximum of 515 nm. If using in a multi-color panel design, filter optimization may be required depending on other fluorophores used. Zombie Green™ dye has similar emission to FITC. Standard Cell Staining Protocol: Prior to reconstitution, spin down the vial of lyophilized reagent in a microcentrifuge to ensure the reagent is at the bottom of the vial. For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie Green™ dye and mix until fully dissolved Wash cells with PBS buffer (no Tris buffer and protein free). Dilute Zombie Green™ dye at 1:100-1000 in PBS. Resuspend 1-10 x 106 cells in diluted 100 µL Zombie Green™ solution. To minimize background staining of live cells, titrate the amount of dye and/or number of cells per 100 µL for optimal performance. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death. Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS. Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells. Incubate the cells at room temperature (or 4°C), in the dark, for 15-30 minutes. Wash one time with 2 mL BioLegend’s Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing serum or BSA. Continue performing antibody staining procedure as desired. Cells can be fixed with paraformaldehyde or methanol prior to permeabilization or can be analyzed without fixation. No-wash Sequential Staining Protocol: Wash cells with PBS buffer (no Tris buffer and protein free). For reconstitution, pre-warm the kit to room temperature; add 100 µL of DMSO to one vial of Zombie Green™ dye and mix until fully dissolved Determine the total µL volume of antibody cocktail previously titrated and optimized for the assay that will be added to each vial/well of cells based on a final volume of 100 µL. Subtract that antibody volume from the 100 µL total staining volume intended for the assay. In the remaining volume, dilute Zombie Green™ dye at 1:100-1000 in PBS as determined by prior optimization at that volume. For example, if you are adding 20 µL of antibody cocktail for a 100 µL total staining volume, use 80 µL of Zombie Green™ solution. Resuspend 1-10 x 106 cells in the appropriate volume of Zombie Green™ solution. Different cell types can have a wide degree of variability in staining based on cell size and degree of cell death. Note: Don’t use Tris buffer as a diluent and be sure that the PBS does not contain any other protein like BSA or FBS. Note: The amount of dye used can also influence the ability to detect apoptotic as well as live and dead cells. Incubate for 10-15 minutes at RT (or 4°C), protected from light. Without washing the cells, add the cell surface antibody cocktail and incubate for another 15-20 minutes. Add 1-2 mL Cell Staining Buffer (Cat. No. 420201) or equivalent buffer containing BSA or serum. Centrifuge to pellet. Continue with normal fixation and permeabilization procedure. If planning to skip fixation and analyze cells live, complete an additional wash step to minimize any unnecessary background of the live cells. Notes: If the cell type in use cannot tolerate a protein-free environment, then titrate the Zombie Green™ dye in the presence of the same amount of BSA/serum as will be present in the antibody staining procedure. A higher amount of Zombie Green™ may be required since the BSA/serum will react with and bind up some proportion of the Zombie Green™. |
|---|
| Additional Product Notes | View more applications data for this product in our Scientific Poster Library. |
|---|
| Product Citations | Iraolagoitia X, et al. 2016. J Immunol. 197: 953 - 961. PubMed Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed Li K, et al. 2022. Cancer Cell. 40:1374. PubMed You S, et al. 2023. Sci Adv. 9:eade7923. PubMed Evans JG, et al. 2023. Viruses. 15:. PubMed Amodeo V, et al. 2023. Dev Cell. 58:836. PubMed Tereshko L, et al. 2021. Elife. 10: . PubMed Martínez-Vélez N, et al. 2022. Mol Cancer Ther. 21:471. PubMed Hsu MA, et al. 2022. Cancer Immunol Immunother. :. PubMed Sweeney-Ambros AR, et al. 2022. J Orthop Res. 40:2843. PubMed Atalis A, et al. 2022. J Control Release. 347:476. PubMed Podico G, et al. 2022. Animals (Basel). 12: . PubMed Foo CX, et al. 2023. Eur Respir J. 61: . PubMed Li S, et al. 2022. Nat Commun. 13:7371. PubMed Subedi N, et al. 2022. Adv Biol (Weinh). :e2200207. PubMed Taniguchi S, et al. 2023. Nat Commun. 14:143. PubMed Gonçalves R, et al. 2023. iScience. 26:105972. PubMed Tsioti I, et al. 2023. J Neuroinflammation. 20:25. PubMed Donado CA, et al. 2020. Cell Reports. 31(1):107466. PubMed Muire P, et al. 2017. PLoS One. 10.1371/journal.pone.0184077. PubMed Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed van der Heide V, et al. 2022. Cell Rep. :110508. PubMed Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed Ireland AS, et al. 2020. Cancer Cell. 38:60. PubMed Akabane S, et al. 2016. J Biol Chem. 291: 16162 - 16174. PubMed Kelsey E Sivick et al. 2018. Cell reports. 25(11):3074-3085 . PubMed Freemerman AJ, et al. 2019. J Immunol. 202:1265. PubMed Darnaud M, et al. 2021. Nat Commun. 12:6686. PubMed Agarwal P, et al. 2021. Heliyon. 7:e06210. PubMed Krauss PL, et al. 2021. Front Immunol. 12:730672. PubMed Bhatt B, et al. 2020. Methods Mol Biol. 2121:93. PubMed Swartz AM, et al. 2022. Curr Protoc. 2:e410. PubMed Brennan FH, et al. 2022. Nat Commun. 13:4096. PubMed Ercoli G, et al. 2022. Clin Transl Immunology. 11:e1366. PubMed Li K, et al. 2021. Sci Adv. 7: . PubMed Van Eyndhoven LC, et al. 2021. Front Immunol. 12:672729. PubMed Garcia-Valtanen P, et al. 2022. Cell Rep Med. 3:100651. PubMed Peña FJ, et al. 2018. Cytometry B Clin Cytom. 94:302. PubMed Fabian P, et al. 2022. Nat Commun. 13:13. PubMed Rubin SJS, et al. 2019. Nat Commun. 10:2686. PubMed Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed Lago-Alvarez Y, et al. 2020. Animals (Basel). 10:00. PubMed Kaddatz H, et al. 2020. Glia. 69:925. PubMed Ma Q, et al. 2022. Vaccines (Basel). 10:. PubMed Zufferey R, et al. 2017. PLoS One. 10.1371/journal.pone.0181432. PubMed Cho S, et al. 2019. Transl Oncol. 0.820138889. PubMed Segabinazzi LGTM, et al. 2021. Antibiotics (Basel). 10: . PubMed Jatho A, et al. 2022. Cells. 11:. PubMed Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed Orozco SL, et al. 2019. Cell Rep. 28:2275. PubMed |
|---|
| Biology Area | Apoptosis/Tumor Suppressors/Cell Death, Cell Biology, Neuroscience |
|---|
| Gene ID | NA |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Fixable Dye, Fixable Viability Dye, Dead, Apoptosis |
|---|
